{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:35:50Z","timestamp":1789839350484,"version":"4.0.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate the impact of dose-specific logic for tricyclic antidepressant (TCA) pharmacogenomics (PGx) clinical decision support (CDS). We aimed to provide guidance in an area with limited supporting literature, ensure optimal dosing through CDS, and limit alert fatigue. The primary outcome was the reduction in alerts prescribers encountered, while the secondary outcome included an analysis across specialties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective chart review was conducted to examine TCA PGx CDS before and after implementation of dosing criteria for alerts. Data were abstracted from the electronic medical record. A \u03c72 test was performed to analyze the frequency of alerts in behavioral health and other specialties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the cohort lacking dose criteria, most TCA orders were for indications other than depression (76%) and guidelines would not apply to the majority of these orders. Using dosing criteria to refine CDS reduced the volume of TCA alerts by 74.8%. Alert volume decreased the most in specialties other than behavioral health due to prescriptions for indications other than anxiety or depression (P = 0.035).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Dose-centric alerts may be used as a strategy to achieve optimal dosing. Alerting clinicians when dose modifications should occur contributes to getting the right dose to the right patient. Future efforts should focus on optimal dosing of medication through CDS enhancements.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxae337","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T15:20:53Z","timestamp":1730906453000},"page":"e457-e464","source":"Crossref","is-referenced-by-count":5,"title":["Impact of using dosing criteria to refine pharmacogenomic clinical decision support for tricyclic antidepressants"],"prefix":"10.1093","volume":"82","author":[{"given":"Amanda","family":"Massmann","sequence":"first","affiliation":[{"name":"Sanford Imagenetics, Sanford Health , Sioux Falls, SD"},{"name":"University of South Dakota School of Medicine Department of Internal Medicine, , Vermillion, SD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Petry","sequence":"additional","affiliation":[{"name":"Sanford Imagenetics, Sanford Health , Sioux Falls, SD"},{"name":"North Dakota State University Department of Pharmacy Practice, , Fargo, ND ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Mills","sequence":"additional","affiliation":[{"name":"Department of Veterans Affairs , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adwoa","family":"Adjekum","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Services, Sanford Medical Center , Fargo, ND ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Van Heukelom","sequence":"additional","affiliation":[{"name":"Sanford Imagenetics, Sanford Health , Sioux Falls, SD"},{"name":"University of South Dakota School of Medicine Department of Internal Medicine, , Vermillion, SD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,9]]},"reference":[{"key":"2025042910463966900_CIT0001","article-title":"Elavil (amitriptyline hydrochloride) tablet","year":"2016"},{"key":"2025042910463966900_CIT0002","article-title":"Amitriptyline","year":"2020"},{"key":"2025042910463966900_CIT0003","article-title":"Anafranil (clomipramine hydrochloride) capsule","year":"2023"},{"key":"2025042910463966900_CIT0004","article-title":"Clomipramine","year":"2020"},{"key":"2025042910463966900_CIT0005","article-title":"Silenor (doxepin hydrochloride) tablet","year":"2023"},{"key":"2025042910463966900_CIT0006","article-title":"Doxepin (systemic)","year":"2020"},{"key":"2025042910463966900_CIT0007","article-title":"Tofranil (imipramine hydrochloride) tablet","year":"2016"},{"key":"2025042910463966900_CIT0008","article-title":"Imipramine","year":"2020"},{"key":"2025042910463966900_CIT0009","article-title":"Trimipramine maleate capsule","year":"2022"},{"key":"2025042910463966900_CIT0010","article-title":"Trimipramine","year":"2020"},{"key":"2025042910463966900_CIT0011","article-title":"Pamelor (nortriptyline hydrochloride) capsule","year":"2020"},{"key":"2025042910463966900_CIT0012","article-title":"Nortriptyline","year":"2020"},{"key":"2025042910463966900_CIT0013","article-title":"Norpramin (desipramine hydrochloride) tablet","year":"2023"},{"key":"2025042910463966900_CIT0014","article-title":"Desipramine","year":"2020"},{"issue":"11","key":"2025042910463966900_CIT0015","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1177\/0706743720915420","article-title":"Pharmacological treatment of mood disorders and comorbid addictions: a systematic review and meta-analysis","volume":"65","author":"Stokes","year":"2020","journal-title":"Can J Psychiatry"},{"issue":"1","key":"2025042910463966900_CIT0016","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s0165-0327(99)00092-0","article-title":"Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability","volume":"58","author":"Anderson","year":"2000","journal-title":"J Affect Disord"},{"issue":"1","key":"2025042910463966900_CIT0017","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/cpt.597","article-title":"Clinical Pharmacogenetics Implementation Consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update","volume":"102","author":"Hicks","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"2025042910463966900_CIT0018","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/jac5.1892","article-title":"Pharmacogenomics to support mental health medication therapy management: clinical practice considerations and a conceptual framework to enhance patient care","volume":"7","author":"Bishop","year":"2024","journal-title":"J Am Coll Clin Pharm"},{"issue":"1","key":"2025042910463966900_CIT0019","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/a-1288-1061","article-title":"Review and consensus on pharmacogenomic testing in psychiatry","volume":"54","author":"Bousman","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"2025042910463966900_CIT0020","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41746-020-0221-y","article-title":"An overview of clinical decision support systems: benefits, risks, and strategies for success","volume":"3","author":"Sutton","year":"2020","journal-title":"NPJ Digit Med"},{"issue":"4","key":"2025042910463966900_CIT0021","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/cpt.2711","article-title":"Pharmacogenomic clinical decision support: a scoping review","volume":"113","author":"Smith","year":"2023","journal-title":"Clin Pharmacol Ther"},{"issue":"15","key":"2025042910463966900_CIT0022","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/ajhp\/zxad100","article-title":"Impact of transitioning to an active, noninterruptive CYP2C19\/proton pump inhibitor alert on prescribing patterns","volume":"80","author":"Massmann","year":"2023","journal-title":"Am J Health-Syst Pharm"},{"issue":"3","key":"2025042910463966900_CIT0023","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1177\/08971900211049589","article-title":"Impact of automated best practice advisories on provider response to CYP2C19 genotyping results for patients on clopidogrel","volume":"36","author":"Petry","year":"2023","journal-title":"J Pharm Pract"},{"key":"2025042910463966900_CIT0024","doi-asserted-by":"publisher","first-page":"626845","DOI":"10.3389\/fgene.2021.626845","article-title":"Precision population medicine in primary care: the Sanford Chip experience","volume":"12","author":"Christensen","year":"2021","journal-title":"Front Genet"},{"issue":"9","key":"2025042910463966900_CIT0025","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2217\/pgs-2023-0016","article-title":"Congruence rates for pharmacogenomic noninterruptive alerts","volume":"24","author":"Mills","year":"2023","journal-title":"Pharmacogenomics"},{"issue":"16","key":"2025042910463966900_CIT0026","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/ajhp\/zxae083","article-title":"Implementation of CYP2C19 and CYP2D6 genotyping to guide antidepressant use in a large rural health system","volume":"81","author":"Petry","year":"2024","journal-title":"Am J Health-Syst Pharm"},{"issue":"18","key":"2025042910463966900_CIT0027","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2217\/pgs-2022-0148","article-title":"Leveraging clinical decision support to reduce the risk of discordant pharmacogenomics results","volume":"23","author":"Massmann","year":"2022","journal-title":"Pharmacogenomics"},{"issue":"17","key":"2025042910463966900_CIT0028","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.2217\/pgs-2020-0088","article-title":"Malignant hyperthermia susceptibility: utilization of genetic results in an electronic medical record to increase safety","volume":"21","author":"Baye","year":"2020","journal-title":"Pharmacogenomics"},{"issue":"3","key":"2025042910463966900_CIT0029","doi-asserted-by":"publisher","first-page":"375","DOI":"10.20517\/jtgg.2022.12","article-title":"Development and early evaluation of clinical decision support for long QT syndrome population screening","volume":"6","author":"Baye","year":"2022","journal-title":"J Transl Genet Genomics."},{"issue":"1","key":"2025042910463966900_CIT0030","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1055\/s-0039-3402757","article-title":"Reducing interruptive alert burden using quality improvement methodology","volume":"11","author":"Chaparro","year":"2020","journal-title":"Appl Clin Inform."},{"issue":"1","key":"2025042910463966900_CIT0031","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0039-3402715","article-title":"Reducing alert burden in electronic health records: state of the art recommendations from four health systems","volume":"11","author":"McGreevey","year":"2020","journal-title":"Appl Clin Inform."},{"issue":"7831","key":"2025042910463966900_CIT0032","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41586-020-2817-4","article-title":"Strategic vision for improving human health at the forefront of genomics","volume":"586","author":"Green","year":"2020","journal-title":"Nature"},{"issue":"3","key":"2025042910463966900_CIT0033","doi-asserted-by":"publisher","first-page":"E24","DOI":"10.3390\/jpm8030024","article-title":"Physician-reported benefits and barriers to clinical implementation of genomic medicine: a multi-site IGNITE-Network survey","volume":"8","author":"Owusu Obeng","year":"2018","journal-title":"J Pers Med"},{"issue":"1","key":"2025042910463966900_CIT0034","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.gim.2021.08.008","article-title":"Improved provider preparedness through an 8-part genetics and genomic education program","volume":"24","author":"Hajek","year":"2022","journal-title":"Genet Med"},{"issue":"5","key":"2025042910463966900_CIT0035","doi-asserted-by":"publisher","first-page":"e2312443","DOI":"10.1001\/jamanetworkopen.2023.12443","article-title":"Effectiveness of genotype-specific tricyclic antidepressant dosing in patients with major depressive disorder: a randomized clinical trial","volume":"6","author":"Vos","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxae337\/60701920\/zxae337.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/82\/9\/e457\/60701920\/zxae337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/82\/9\/e457\/60701920\/zxae337.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T11:12:46Z","timestamp":1745925166000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/82\/9\/e457\/7888788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,9]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,11,9]]},"published-print":{"date-parts":[[2025,4,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxae337","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5,1]]},"published":{"date-parts":[[2024,11,9]]}}}